Jansen Jeroen P
Mapi Values, Houten, The Netherlands.
Curr Med Res Opin. 2006 Apr;22(4):671-81. doi: 10.1185/030079906X96308.
To evaluate the relative effectiveness of interventions with self-monitoring blood glucose and self-monitoring of urine glucose, versus interventions without self-monitoring, in terms of HbA(1c) reductions in type 2 diabetes mellitus.
Thirteen published full reports on randomised controlled trials investigating the effects of self-monitoring glucose were identified by a systematic search of Medline, Embase, the Cochrane Library (1966-Nov 2005) and previous reviews. Three types of studies were included: self-monitoring of blood glucose versus no self-monitoring, self-monitoring of blood glucose versus self-monitoring of urine glucose and self-monitoring of blood glucose with regular feedback versus monitoring without feedback. The internal validity of studies was assessed systematically by two reviewers, using 13 criteria of a validated list. Results from the three types of studies were analysed simultaneously with a Bayesian metaanalysis of direct and indirect comparisons.
Adjusted for baseline HbA(1c) level and internal validity, interventions with self-monitoring of blood glucose showed a reduction in HbA(1c) of 0.40 percentage-points (%) (95% credible interval [CrI] 0.07 to 0.70%) in comparison to interventions without self-monitoring. Regular feedback more than doubled the HbA(1c) reduction. Self-monitoring of urine glucose showed comparable results to interventions without self-monitoring (0.02% decrease in HbA(1c); 95% CrI -0.62 to 0.70%). There is a 88% probability that interventions with self-monitoring blood glucose are more effective than interventions with urine glucose monitoring (relative reduction in HbA(1c) is 0.38%, 95% CrI -0.30 to 1.00%).
The randomized clinical trials performed to date provided positive results on the effectiveness of interventions with self-monitoring of blood glucose in type 2 diabetes mellitus. Regular medical feedback of the monitored HbA(1c) levels is important. Furthermore, self-monitoring of blood glucose is likely to be more effective than self-monitoring of urine glucose.
评估自我监测血糖和自我监测尿糖的干预措施与不进行自我监测的干预措施相比,在降低2型糖尿病患者糖化血红蛋白(HbA1c)方面的相对有效性。
通过系统检索Medline、Embase、Cochrane图书馆(1966年至2005年11月)及以往综述,确定了13篇关于研究自我监测血糖效果的已发表随机对照试验的完整报告。纳入了三种类型的研究:自我监测血糖与不进行自我监测、自我监测血糖与自我监测尿糖、自我监测血糖并定期反馈与无反馈监测。由两名评审员使用经过验证的列表中的13项标准对研究的内部有效性进行系统评估。对这三种类型研究的结果进行直接和间接比较的贝叶斯荟萃分析。
在调整基线HbA1c水平和内部有效性后,与不进行自我监测的干预措施相比,自我监测血糖的干预措施使HbA1c降低了0.40个百分点(95%可信区间[CrI]为0.07至0.70%)。定期反馈使HbA1c降低幅度增加了一倍多。自我监测尿糖与不进行自我监测的干预措施结果相当(HbA1c降低0.02%;95%CrI为-0.62至0.70%)。自我监测血糖的干预措施比尿糖监测干预措施更有效的概率为88%(HbA1c相对降低0.38%,95%CrI为-0.30至1.00%)。
迄今为止进行的随机临床试验表明,自我监测血糖的干预措施对2型糖尿病有效。对监测的HbA1c水平进行定期医学反馈很重要。此外,自我监测血糖可能比自我监测尿糖更有效。